Skip to main content
. 2021 Mar 8;113(9):1212–1220. doi: 10.1093/jnci/djab029

Figure 3.

Figure 3.

Kaplan-Meier survival curves for recurrence-free survival (A) and overall survival (B) for patients with methylated mismatch repair deficient (MMRd), other MMRd and Lynch syndrome (LS) associated MMRd endometrial cancer (EC). All cases with MMRd phenotype are included in this analysis, including cases with a concurrent POLE variant affecting function (POLEmut-MMRd-EC). P values reflect 2-sided log-rank test.